There were also no significant differences in Notch2 mRNA in either peripheral or BALF CD4+ T cells between EGFR mutation and non-EGFR mutation lung adenocarcinoma patients (P=0.503 and 0.810, respectively, Figure 1G,H). Here, CD4 is linked to lung adenocarcinoma.